Defunct Company
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
104
NCT05172544
Trial of an Inactivated Yellow Fever Virus Vaccine
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 13, 2022
Completion: Apr 24, 2023
NCT06366009
Assessment of Patients With Drug-resistant Temporal Lobe Epilepsy With EEG Extended With Intra-auricular Electrodes
Phase: N/A
Role: Collaborator
Start: Apr 8, 2024
Completion: Jul 31, 2024
NCT06669208
Trial of an Inactivated Chikungunya Virus Vaccine
Start: Nov 4, 2024
Completion: Feb 20, 2026